Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chemotrade, GmbH
Isonics wins key brachytherapy order
January 14th, 2004
Isonics Corp. (ISON), a supplier of silicon-on-insulator wafers and isotopes for life sciences and healthcare applications, announced that Chemotrade, GmbH, its wholly owned life science subsidiary, has won an order from International Brachytherapy, s.a., (IBt) to supply Iodine-125 for delivery in 2004. Isonics expects to generate revenue from $400,000-500,000 depending on actual quantities shipped, which represents a substantial increase from previous years. Belgium-based IBt is focused on the manufacture of brachytherapy seeds and seed-delivery systems used to treat prostate cancer. Iodine-125 is the "active ingredient" in one version of IBt's...
Source: Biotech Week (2004-01-14)
|
